ChitogenX Inc.
CHNXF
$0.0071
-$0.0039-35.46%
| Weiss Ratings | CHNXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | CHNXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | CHNXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.55 | |||
| Price History | CHNXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | -52.67% | |||
| 90-Day Total Return | 39.22% | |||
| Year to Date Total Return | -52.67% | |||
| 1-Year Total Return | -81.98% | |||
| 2-Year Total Return | -95.14% | |||
| 3-Year Total Return | -94.99% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -85.80% | |||
| 52-Week Low % Change | 40.59% | |||
| Price | CHNXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.05 | |||
| 52-Week Low Price | $0.01 | |||
| 52-Week Low Price (Date) | Nov 19, 2024 | |||
| 52-Week High Price (Date) | Apr 19, 2024 | |||
| Valuation | CHNXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 580.85K | |||
| Enterprise Value | 3.51M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.01 | |||
| Earnings Per Share Growth | -66.75% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -0.11 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.01 | |||
| Enterprise Value/EBITDA (TTM) | -3.41 | |||
| Enterprise Value/EBIT | -3.31 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | CHNXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 83.13M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CHNXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 514 261 4735 | |||
| Address | 16667 Hymus Boulevard Kirkland, QC H9H 4R9 | |||
| Website | www.chitogenx.com | |||
| Country | Canada | |||
| Year Founded | 2015 | |||
| Profitability | CHNXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | CHNXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -156.02% | |||
| Return on Equity | -- | |||
| Income Statement | CHNXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -949.70K | |||
| EBIT (TTM) | -976.70K | |||
| Net Income (TTM) | -1.14M | |||
| Net Income Avl. to Common (TTM) | -1.14M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 23.12% | |||
| EPS Diluted (TTM) | -0.01 | |||
| EPS Diluted Growth (Q YOY) | 26.39% | |||
| Balance Sheet | CHNXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 34.40K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 80.40K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -5.28M | |||
| Current Ratio (Q) | 0.015 | |||
| Book Value Per Share (Q) | -$0.06 | |||
| Total Assets (Q) | 276.30K | |||
| Total Current Liabilities (Q) | 5.48M | |||
| Total Debt (Q) | 3.04M | |||
| Total Liabilities (Q) | 5.56M | |||
| Total Common Equity (Q) | -5.28M | |||
| Cash Flow | CHNXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 55.30K | |||
| Net Change in Cash (TTM) | -46.70K | |||
| Levered Free Cash Flow (TTM) | -30.70K | |||
| Cash from Operations (TTM) | -113.10K | |||
